The Trump Administration appears to be prioritizing its MFN price negotiations over the Medicare price negotiation program. (Screenshot of White House Broadcast)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
